Acute sinusoidal obstruction syndrome after 6-thioguanine therapy for Crohn's disease

Inflammatory Bowel Diseases

Volumn 10, Issue 5, 2004, Pages 652-654

  Kane, Sunanda ^a   Cohen, Stanley M ^a   Hart, John ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Crohn's disease; Liver toxicity; Thioguanine

Indexed keywords

ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; AZATHIOPRINE; GAMMA GLUTAMYLTRANSFERASE; INFLIXIMAB; LIVER ENZYME; PREDNISONE; SALAZOSULFAPYRIDINE; TIOGUANINE;

ADULT; ANUS FISTULA; ARTICLE; CASE REPORT; CLINICAL FEATURE; CROHN DISEASE; DRUG HYPERSENSITIVITY; DYSPNEA; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HOSPITAL DISCHARGE; HUMAN; HYPERBILIRUBINEMIA; HYPERPHOSPHATEMIA; HYPOTENSION; INCIDENCE; INTRAHEPATIC CHOLESTASIS; LIVER BIOPSY; LIVER SINUSOID; LIVER TOXICITY; MALAISE; MALE; PATIENT REFERRAL; PELVIS ABSCESS; PRIORITY JOURNAL; TACHYCARDIA; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; CROHN DISEASE; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; MALE; SYNDROME; THIOGUANINE;

EID: 4644316814     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200409000-00023     Document Type: Article

References (7)

1. Dubinsky MC, Yang H, Hassard PV, et al. 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease. Gastroenterology. 2002;122:904-915.
2. Griner PF, Elbadawi A, Packman CH. Veno-occlusive disease of the liver after chemotherapy of acute leukemia. Report of two cases. Ann Intern Med. 1976;85:578-582.
3. Gill RA, Onstad GR, Cardamone JM. Maneval DC, Summer HW. Hepatic veno-occlusive disease caused by 6-thioguanine. Ann Intern Med. 1982; 96:58-60.
4. Zackheim HS, Glogau RG, Fisher DA, et al. 6-Thioguanine treatment of psoriasis: experience in 81 patients. J Am Acad Dermatol. 1994;30:452-458.
5. Kao NL, Rosenblate HJ. 6-Thioguanine therapy for psoriasis causing toxic hepatic veno-occlusive disease. J Am Acad Dermatol. 1993;28: 1017-1018.
6. Derijks LJ, DeJong DJ, Gilissen LP, et al. 6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine intolerant inflammatory bowel disease patients: a short-term safety assessment. Eur J Gastroenterol Hepatol. 2003;15:63-67.
7. Dubinsky MC, Vasiliasuskas EA, Singh H, et al. 6-Thioguanine can cause seroiud liver injury in inflammatory bowel disease patients. Gastroenterology. 2003;125:298-303.